Nature

Pelvic lymph node dissection in prostate cancer, still no level 1 evidence of oncological benefit. Time to consider surveillance of negative pelvic lymph nodes on PSMA PET scan ...

In a single centre prospective trial, Zhou J et al. [1] examined the therapeutic benefit of performing an extended pelvic lymph node dissection (ePLND) at radical prostatectomy (RP) by randomising 100 ...
Nature

A novel nomogram incorporating lymphovascular invasion to predict lymph node invasion in high-risk prostate cancer

Accurate preoperative prediction of lymph node invasion (LNI) is essential for selecting candidates for extended pelvic lymph node dissection (ePLND) in high-risk prostate cancer. Although ePLND ...
ascopubs.org

Evaluating the efficacy and safety of pelvic lymph node dissection in high-risk prostate cancer patients undergoing radical prostatectomy: A systematic review and meta-analysis.

Fifteen-year outcomes of external radiation with or without 6 months of neoadjuvant deprivation therapy for intermediate risk prostate cancer. This is an ASCO Meeting Abstract from the 2025 ASCO ...
ascopubs.org

Radiographic recurrence patterns for prostate cancer with pathologic lymph node involvement following PSMA-PET and radical prostatectomy.

Short-course (3-month) enzalutamide monotherapy in biochemically recurrent prostate cancer (BCR): Preliminary prostate specific membrane antigen tumor volume (PSMA-TV) data. Anatomical location of ...
MedPage Today

Pelvic Lymph Node Dissection: Is It Necessary in Prostate Cancer Surgery?

According to a new analysis, PLND does not impact recurrence-free survival but may reduce metastatic spread in intermediate- and high-risk prostate cancer. The benefit of PLND is most evident in ...